Pacritinib moves foward in MF: PAC2013 and PACIFICA
John Mascarenhas, MD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses the use of pacritinib, an oral…
Related Articles
Briquilimab-based conditioning for patients with Fanconi anemia receiving alloSCT
Agnieszka Czechowicz, MD, PhD, Stanford University, Stanford, CA, comments on the use of briquilimab antibody-based conditioning in patients with Fanconi anemia receiving allogeneic stem cell…
Lymphoma Sessions: Exploring the role of BTK inhibitors in frontline and R/R mantle-cell-lymphoma | VJHemOnc
Hear more from leading experts Krish Patel, Craig Portell and Tycel Phillips as they discuss the role of BTK inhibitors in frontline and R/R mantle…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Toxicities associated with BCMA, GPRC5D & FcRH5-targeting bispecifics and advice on their management
Joshua Richter, MD, Mount Sinai Medical Center, New York City, NY, outlines the common toxicities associated with BCMA, GPRC5D, and FcRH5-targeting bispecific antibodies used for…
Approaches to newly diagnosed myeloma and the rapidly evolving landscape
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, provides a comprehensive summary of his talk on approaches to newly diagnosed multiple myeloma (MM) and the…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Increased risk of leukemic transformation and worse survival in patients with TP53-mutated MPNs
Shivani Handa, MD, The Ohio State University Wexner Medical Center, Columbus, OH, comments on the prognostic impact of TP53 mutations in patients with myeloproliferative neoplasms…
Treatment failure patterns in second-line versus third-line introduction of CAR-T therapy in LBCL
Roni Shouval, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the treatment failure patterns of patients with large B-cell lymphoma (LBCL)…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
The evolving role of nurses in the CAR T-cell therapy process
Mairéad Ní Chonghaile, RGN, BNS, MSc, St James’s Hospital, Dublin, Ireland, comments on the evolving role of nurses in the CAR T-cell therapy process, highlighting…